Search

Current filters: Treatment, HIV drugs, Side effects

Dolutegravir and TAF or TDF—safety issues and weight gain

From TreatmentUpdate 235
2020, CATIE
Research summary - Webpage

From wasting to obesity—the changing issue of weight in HIV

From TreatmentUpdate 235
2020, CATIE
Research summary - Webpage

Higher levels of dolutegravir in older people not linked to side effects

From TreatmentUpdate 230
2019, CATIE
Research summary - Webpage

Large French study examines neuropsychiatric side effects with integrase inhibitors

From TreatmentUpdate 230
2019, CATIE
Research summary - Webpage

Agencies issue caution about use of dolutegravir by pregnant HIV-positive women

2018, CATIE
Research summary - Webpage

Does tenofovir (TDF) cause liver injury?

2016, CATIE
Research summary - Webpage

Genvoya approved in Canada—What you need to know

From TreatmentUpdate 212
2016, CATIE
Research summary - Webpage

TAF in people with kidney dysfunction

From TreatmentUpdate 211
2015, CATIE
Research summary - Webpage

A study about switching from TDF to TAF

From TreatmentUpdate 211
2015, CATIE
Research summary - Webpage

TAF vs. TDF (original tenofovir)—improvements in safety

From TreatmentUpdate 211
2015, CATIE
Research summary - Webpage